Haruyo Yamanishi

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Shiseido Company, Limited. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruyo Yamanishi. Retrieved from https://idiyas.com/inventor/haruyo-yamanishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Kanagawa, JP (2015)
Yokohama, JP (2012 - 2022)

Company Filing History:

5 out of 1,040

Shiseido Company, Limited

patents

Years Active: 2012-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11427807 - Serum-free medium containing PDGF for DS cells (2022-08-30),

2. 10391137 - Platelet-derived growth factor-BB production promotor, and mesenchymal stem cell production accelerator, stem cell stabilizer and dermal regenerator comprising the same (2019-08-27),

3. 10017817 - Skin activation by acceleration of PDGF-BB activity (2018-07-10),

4. 8962323 - Method of isolating dermal stem cells (2015-02-24),

5. 8334136 - Method for promoting hair growth or hair regeneration by maintaining or increasing expression of cell-adhesion factor (2012-12-18),

Title: Haruyo Yamanishi: Innovator in Stem Cell Research

Introduction

Haruyo Yamanishi is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of stem cell research, holding a total of 5 patents. Her work focuses on developing innovative methods and mediums for culturing dermal sheath cells and promoting the production of essential growth factors.

Latest Patents

One of her latest patents is a serum-free medium containing platelet-derived growth factor (PDGF) for dermal sheath (DS) cells. This invention relates to a method for culturing DS cells using a serum-free medium that comprises PDGF. Another notable patent is an agent that promotes the production of platelet-derived growth factor-BB (PDGF-BB) and accelerates mesenchymal stem cell production. This agent includes components such as cowberry derivatives, mangosteen derivatives, root derivatives, inositol, and inositol phosphate, which serve as active ingredients to stabilize stem cells and enhance dermal regeneration.

Career Highlights

Haruyo Yamanishi is currently associated with Shiseido Company, Limited, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the advancement of stem cell technologies.

Collaborations

Throughout her career, Haruyo has collaborated with notable colleagues, including Tsutomu Soma and Yuzo Yoshida. These partnerships have contributed to her success and the impact of her inventions in the scientific community.

Conclusion

Haruyo Yamanishi's contributions to stem cell research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence advancements in medical science and regenerative therapies.

Profile summary based on public USPTO records.